2015
DOI: 10.1016/j.bios.2014.08.044
|View full text |Cite
|
Sign up to set email alerts
|

Glucose-driven chemo-mechanical autonomous drug-release system with multi-enzymatic amplification toward feedback control of blood glucose in diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 33 publications
0
4
0
Order By: Relevance
“…MENAs-mediated drug release has attracted a lot of research attention. 216 For instance, glucose-responsive controlled insulin release nanosystems have been widely constructed with assembled GOx and CAT. 217,218 One recent example used the two enzymes-PEI complex to coat insulin-loaded silica nanovesicles (SV).…”
Section: Pharmaceutical Industry and Drug Deliverymentioning
confidence: 99%
“…MENAs-mediated drug release has attracted a lot of research attention. 216 For instance, glucose-responsive controlled insulin release nanosystems have been widely constructed with assembled GOx and CAT. 217,218 One recent example used the two enzymes-PEI complex to coat insulin-loaded silica nanovesicles (SV).…”
Section: Pharmaceutical Industry and Drug Deliverymentioning
confidence: 99%
“…In single-channel electrophysiological measurements, single-molecule translocation experiments showed that the synthetic channels could be used to discriminate single DNA molecules [42]. Moreover, a secondgeneration glucose-driven novel chemo-mechanical autonomous drug release system was fabricated and evaluated toward feedback control of blood glucose in diabetes, without any requirement for external energy [43]. One of the most active directions in synthetic protocell biology is the "reconstruction' approach", where macromolecules are encapsulated in vesicles or liposomes and catalyze metabolic functions necessary in the life cycle of the protocell [44,45].…”
Section: In Vitro and In Vivo Systemsmentioning
confidence: 99%
“…Diabetes occurrence is becoming more and more widespread around the world [1,2], and glucose is regarded as the most iconic biomarker for diabetes detection [3][4][5]. It is indispensable to develop glucose sensing technology in food processing, environmental monitoring, biological process control, and especially in blood glucose detection [6][7][8][9].…”
Section: Introductionmentioning
confidence: 99%